| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.07 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |